The Mednet is a technology company.
The Mednet has raised $1.0M across 1 funding round.
The Mednet has raised $1.0M in total across 1 funding round.
The Mednet has raised $1.0M in total across 1 funding round.
The Mednet's investors include 6th Man Ventures, Addition, Andreessen Horowitz, Ascension Ventures, Audrey Capital, Balderton Capital, Benchmark, Bowery Capital, Buckley Ventures, Canvas Ventures, Daffy, DCM.
MedNet Solutions is a healthcare technology company specializing in eClinical solutions, particularly its flagship iMednet platform, which provides electronic data capture (EDC) and related tools for clinical trials in the life sciences sector.[1][2][3] It serves pharmaceutical, biotech, medical device sponsors, and contract research organizations (CROs) worldwide, solving inefficiencies in clinical study management by offering flexible, intuitive tools that accelerate study startup, data collection, and oversight across all therapeutic areas and study sizes.[2][3] With over 24 years of experience, thousands of studies in 100+ countries, 83,800+ site users, and strong customer satisfaction (4.9 average reviews), MedNet demonstrates robust growth, including a recent acquisition by CRScube to expand eClinical capabilities.[2][3]
MedNet Solutions was founded over 24 years ago, marking its 20th anniversary in 2021, with headquarters in Minnetonka, Minnesota.[2][3][4] While specific founders are not detailed in available sources, the company has been led by Rob Robertson as President and CEO, who has emphasized its enduring mission to deliver innovative eClinical solutions amid industry evolution.[2] Early traction came from pioneering EDC technologies, growing to support thousands of global studies for medical device, pharma, and biotech sponsors; pivotal moments include expanding the Mednet Value Program (MVP) in 2021 for CRO partnerships and the 2025 acquisition by CRScube, enhancing its platform's reach.[2][3][4]
MedNet stands out in the eClinical space through these key strengths:
MedNet rides the wave of digital transformation in clinical trials, where rising complexity, global scale, and AI integration demand efficient eClinical tools amid post-pandemic decentralization and faster drug development needs.[2][3] Its timing aligns with market forces like regulatory pressures for compliance, cost containment, and data-driven insights, enabling life sciences firms to optimize trials without fragmented vendors.[5] By powering studies across pharma, biotech, and devices in 100+ countries, MedNet influences the ecosystem through CRO partnerships and innovations like AI-enhanced oversight, reducing timelines and improving healthcare outcomes globally.[2][3][4]
MedNet's integration with CRScube positions it for accelerated innovation in AI-driven eClinical tools, potentially expanding into advanced analytics and global trial automation.[2] Trends like AI automation, decentralized trials, and real-world evidence will shape its path, amplifying efficiency for resource-strapped biotechs. Its influence may grow as a go-to EDC leader, fostering more seamless clinical research and tying back to its core strength: empowering life sciences to focus on patient impact over operational hurdles.[2][3]
The Mednet has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2017 | $1.0M Seed | 6th Man Ventures, Addition, Andreessen Horowitz, Ascension Ventures, Audrey Capital, Balderton Capital, Benchmark, Bowery Capital, Buckley Ventures, Canvas Ventures, Daffy, DCM, Electric Capital, Footwork, General Catalyst, Gigascale Capital, Goat Capital, Greylock, Hanabi Capital, Healthy Ventures, Homebrew, Human Capital, Innovation Works, Kindred Ventures, Kleiner Perkins, LAUNCH, Leadout Capital, Pioneer Fund, Presence Capital, Quiet Capital, Red Swan Ventures, Gil Penchina, Science, Social Capital, South Park Commons, Spark Capital, The General Partnership, True Ventures, UpHonest Capital, VitalStage Ventures, Y Combinator, Adam D'Angelo, Adrian Aoun, Alex Pattis, Alison Pincus, Charlie Songhurst, Chris Fanini, Desmond Lim, Dharmesh Shah, Emmett Shear, Immad Akhund, Jonathan Bush, Karim Atiyeh, Kevin Lin, Kyle Vogt, Manish Shah, Marissa Mayer, Mark Pincus, Matt Brezina, Matt Cutts, Michał Borkowski, Mikhail Seregine, Paul McKellar, Rene Reinsberg, Sam Altman, Samvit Ramadurgam, Sohail Prasad, Tikhon Bernstam, Tim Ferriss, Tim Kendall, Tirto Adji, Travis Vanderzanden, Wayne Chang |